Literature DB >> 34053939

Large for Gestational Age and Obesity-Related Comorbidities.

Yong Hee Hong1, Ji-Eun Lee2.   

Abstract

Both small for gestational age and large for gestational age (LGA) size at birth are associated with metabolic complications throughout life. The long-term consequences of LGA have been investigated in only a few studies. LGA is thought to be associated with early obesity and metabolic risk. Understanding how LGA can influence later obesity risk is important for pediatric obesity interventions. Pregnant women who are overweight or obese are at high risk of having LGA babies. Infants born LGA are at increased risk of becoming overweight or obese children, adolescents, and young adults and can have an increased risk of metabolic syndrome later in life and giving birth to LGA offspring. Education and intervention for weight control before and during pregnancy should be conducted to prevent LGA births. Particular attention is needed for women of childbearing age who are diabetic and obese, which could be the starting point for lifelong management of obesity.

Entities:  

Keywords:  Birth weight; Comorbidity; Gestational age; Obesity

Year:  2021        PMID: 34053939     DOI: 10.7570/jomes20130

Source DB:  PubMed          Journal:  J Obes Metab Syndr        ISSN: 2508-6235


  4 in total

1.  The Associations of Maternal Hemoglobin Concentration in Different Time Points and Its Changes during Pregnancy with Birth Weight Outcomes.

Authors:  Zhicheng Peng; Shuting Si; Haoyue Cheng; Haibo Zhou; Peihan Chi; Minjia Mo; Yan Zhuang; Hui Liu; Yunxian Yu
Journal:  Nutrients       Date:  2022-06-19       Impact factor: 6.706

2.  Pediatric obesity: life cycle approach of pediatrician and society.

Authors:  Yong Hee Hong
Journal:  Clin Exp Pediatr       Date:  2021-12-28

3.  Mouse Model of Small for Gestational Age Offspring with Catch-up Growth Failure and Dysregulated Glucose Metabolism in Adulthood.

Authors:  Hyeon Seok Moon; Hanbin Kim; Bohye Kim; Min-Seon Kim; Jae Hyun Kim; Obin Kwon
Journal:  J Obes Metab Syndr       Date:  2022-03-30

4.  Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients' offspring.

Authors:  Hieronymus T W Smeele; Esther Röder; Annemarie G M G J Mulders; Eric A P Steegers; Radboud J E M Dolhain
Journal:  Ann Rheum Dis       Date:  2022-07-11       Impact factor: 27.973

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.